Unique ID issued by UMIN | UMIN000030307 |
---|---|
Receipt number | R000034614 |
Scientific Title | A study to evaluate the safety of excessive ingestion of licorice flavonoid oil for healthy adults. |
Date of disclosure of the study information | 2017/12/18 |
Last modified on | 2018/05/22 09:19:49 |
A study to evaluate the safety of excessive ingestion of licorice flavonoid oil for healthy adults.
A study to evaluate the safety of excessive ingestion of licorice flavonoid oil for healthy adults.
A study to evaluate the safety of excessive ingestion of licorice flavonoid oil for healthy adults.
A study to evaluate the safety of excessive ingestion of licorice flavonoid oil for healthy adults.
Japan |
None
Not applicable | Adult |
Others
NO
To evaluate the safety of excessive ingestion of licorice flavonoid oil containing food for 4 weeks.
Safety
Hematology test
Blood biochemistry test
Urinalysis
Blood pressure/pulsation
Body weight
Doctor's questions
Adverse event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Ingestion of licorice flavonoid oil containing food (5 soft gels per day, 4 weeks)
20 | years-old | <= |
69 | years-old | >= |
Male and Female
Healthy males and females aged 20-69 years.
(1)With allergy to the study foods.
(2)Subjects who has a disease under treatment.
(3)Subjects who has under treatment or a history of serious disease (e.g., diabetes, liver disease, kidney disease, heart disease or cancer).
(4)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire.
(5)Subjects who constantly take in supplement richly containing licorice glabra polyphenol or licorice flavonoid oil.
(6)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination at the screening.
(7)Subjects who have habits affecting research results, such as doing shift work day and night, or Subjects who have a plan that affect research results such as day and night shift work or going overseas.
(8)Subjects who have participated in other clinical study within the last one month prior to the current study.
(9)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
(10)Subjects who are judged as unsuitable by doctor for other reasons.
20
1st name | |
Middle name | |
Last name | Hideyuki Morikawa |
KANEKA CORPORATION
Pharma & Supplemental Nutrition Solutions Vehicle, Supplemental Nutrition Devision
2-3-18, Nakanoshima, Kita-ku, Osaka
050-3133-7673
Hideyuki.Morikawa@kaneka.co.jp
1st name | |
Middle name | |
Last name | Saki Fukuchi |
TTC CO., LTD.
Clinical Research Planning Department
1-20-2 Ebisunishi, Shibuya-ku, Tokyo JAPAN
03-5459-5329
s.fukuchi@ttc-tokyo.co.jp
TTC Co.,Ltd
KANEKA CORPORATION
Profit organization
NO
2017 | Year | 12 | Month | 18 | Day |
Unpublished
Completed
2017 | Year | 11 | Month | 30 | Day |
2017 | Year | 12 | Month | 18 | Day |
2017 | Year | 12 | Month | 08 | Day |
2018 | Year | 05 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034614
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |